Adcentrx Therapeutics Doses First Patient in Phase 1b Expansion Cohorts with ADRX-0706 Nectin-4 ADC
Marks successful completion of Phase 1a dose escalationPhase 1b dose expansion results expected 4Q 2025
Marks successful completion of Phase 1a dose escalationPhase 1b dose expansion results expected 4Q 2025
Please help local businesses by taking an online survey to help us navigate through these unprecedented times. None of the responses will be shared or used for any other purpose except to better serve our community. The survey is at: www.pulsepoll.com $1,000 is being awarded. Everyone completing the survey will be able to enter a contest to Win as our way of saying, "Thank You" for your time. Thank You!